ArticleCardiovascular research2021

Sodium-glucose co-transporter 2 inhibitor empagliflozin inhibits the cardiac Na+/H+ exchanger 1: persistent inhibition under various experimental conditions.

Coert J Zuurbier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.